Search results
Apr 10, 2020 · Gaurav Shukla, writer of the acclaimed crime mystery Asur, talks to Firstpost about the various facets of the show that examines the conflict between science and religion, and everything beyond.
Jun 10, 2023 · The creative team of Asur 2 - creator Gaurav Shukla, director Oni Sen and writer Abhijeet Khuman, graced Pinkvilla with an interview of theirs, where they passionately talked about their...
View Prof. Dr Gaurav Shukla’s profile on LinkedIn, a professional community of 1 billion members. Professor of Taxation and Public Law · In February 2021, I have completed 14 years in the...
- Self-employed
Jun 22, 2023 · Writer, producer Gaurav Shukla spills the beans on creating a befitting sequel and what’s more in store. What took Asur 2 so long?
Location: Bengaluru · 500+ connections on LinkedIn. View Gaurav Shukla’s profile on LinkedIn, a professional community of 1 billion members.
Gaurav Shukla is known for Asur: Welcome to Your Dark Side (2020), Angrezi Medium (2020) and Vulture (2010).
shuklagaurav@deloitte.com. Gaurav is Deloitte Risk Advisory GCC and Growth office leader for the Cyber & Strategic risk practice. He led Deloitte India Cyber portfolio and has over 20 years of proven success in advising global enterprise clients on Cyber strategy, Digital Risk, IoT/OT security, Cloud and Cyber Resilience. Gaurav has strong ...
About. I am a Post doctoral researcher at National Research Council - Institute of Nanoscience (CNR Nano), National Enterprise for nanoScience and nanoTechnology (NEST), Pisa, Italy. Currently, I...
- CNR- Istituto Nanoscienze (CNR NANO)
Jan 11, 2008 · Gaurav Shukla. @gauravshukla. ·. Jun 29. Pathetic experience with. @YESBANK. Regretting taking home loan from it. Everything done from my end but still bank can’t be bothered to release the payment. What’s worse, the bank’s representatives will straight up lie.
Gaurav Shukla, MD, PhD. Radiation Oncology. Dr. Shukla is a graduate of Duke University, where he majored in biomedical and electrical engineering. He joined the Medical Scientist Training Program at the University of Pittsburgh and Carnegie Mellon University, earning his Ph.D. in bioengineering and his M.D. in 2012.
